Table 2.
Relationship of BSG expression and clinicopathological parameters by immunohistochemistry
| Total number | BSG (-) | BSG (+) | Z score | P-value | |
|---|---|---|---|---|---|
| Tissue | |||||
| LUAD | 127 | 64 | 63 | -3.601 | <0.001* |
| pT | 30 | 26 | 4 | ||
| Gender | |||||
| Male | 71 | 36 | 35 | -0.629 | 0.529 |
| Female | 34 | 15 | 19 | ||
| Age | |||||
| ≤60 | 70 | 37 | 33 | -1.237 | 0.216 |
| >60 | 35 | 14 | 21 | ||
| Pathology grade | |||||
| I | 8 | 5 | 3 | 6.368a | 0.041* |
| II | 45 | 24 | 21 | ||
| III | 33 | 9 | 24 | ||
| T stage | |||||
| T1-T2 | 106 | 52 | 54 | -0.674 | 0.5 |
| T3-T4 | 21 | 12 | 9 | ||
| Distant metastasis | |||||
| No | 96 | 49 | 47 | -1.646 | 0.1 |
| Yes | 9 | 2 | 7 | ||
| Lymphatic metastasis | |||||
| No | 82 | 48 | 34 | -2.468 | 0.014* |
| Yes | 45 | 16 | 29 | ||
| Tumor size | |||||
| ≤7 cm | 105 | 51 | 54 | -0.894 | 0.371 |
| >7 cm | 22 | 13 | 9 |
*
P<0.05.